| Year |
Citation |
Score |
| 2008 |
Dong Z, Saliganan AD, Meng H, Nabha SM, Sabbota AL, Sheng S, Bonfil RD, Cher ML. Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover. Neoplasia (New York, N.Y.). 10: 439-49. PMID 18472961 DOI: 10.1593/Neo.08106 |
0.515 |
|
| 2008 |
Chinni SR, Yamamoto H, Dong Z, Sabbota A, Bonfil RD, Cher ML. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. Molecular Cancer Research : McR. 6: 446-57. PMID 18337451 DOI: 10.1158/1541-7786.Mcr-07-0117 |
0.516 |
|
| 2008 |
Nabha SM, dos Santos EB, Yamamoto HA, Belizi A, Dong Z, Meng H, Saliganan A, Sabbota A, Bonfil RD, Cher ML. Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner. International Journal of Cancer. Journal International Du Cancer. 122: 2482-90. PMID 18324629 DOI: 10.1002/Ijc.23431 |
0.596 |
|
| 2008 |
Wiesner C, Nabha S, Burck Dos Santos E, Yamamoto H, Dong Z, Meng H, Melchior S, Thueroff J, Vessella R, Cher M, Bonfil R. IMMUNOLOCALIZATION OF SCF AND C-KIT IN BENIGN AND MALIGNANT PROSTATIC TISSUE European Urology Supplements. 7: 174. DOI: 10.1016/S1569-9056(08)60412-1 |
0.321 |
|
| 2007 |
Bonfil RD, Dong Z, Trindade Filho JC, Sabbota A, Osenkowski P, Nabha S, Yamamoto H, Chinni SR, Zhao H, Mobashery S, Vessella RL, Fridman R, Cher ML. Prostate cancer-associated membrane type 1-matrix metalloproteinase: A pivotal role in bone response and intraosseous tumor growth American Journal of Pathology. 170: 2100-2111. PMID 17525276 DOI: 10.2353/Ajpath.2007.060720 |
0.691 |
|
| 2007 |
Wiesner C, Bonfil RD, Dong Z, Yamamoto H, Nabha SM, Meng H, Saliganan A, Sabbota A, Cher ML. Heterogeneous activation of MMP-9 due to prostate cancer-bone interaction. Urology. 69: 795-9. PMID 17445684 DOI: 10.1016/J.Urology.2007.01.093 |
0.589 |
|
| 2007 |
Yamamoto H, Bonfil RD, Wiesner C, Nabha S, Dong Z, Meng H, Saliganan A, Sabbota A, Chinni SR, Cher ML. Quantitative assessment of small intraosseous prostate cancer burden in SCID mice using fluorescence imaging. The Prostate. 67: 107-14. PMID 17075820 DOI: 10.1002/Pros.20506 |
0.424 |
|
| 2007 |
Chinni SR, Yamamoto H, Dong Z, Sabbota A, Nabha S, Bonfil RD, Cher ML. 664: CXCL12/CXCR4 Trans-Activation of HER2 in Lipid Rafts of Prostate Cancer Cell Membranes Promotes Bone Metastasis The Journal of Urology. 177: 223-223. DOI: 10.1016/S0022-5347(18)30904-2 |
0.461 |
|
| 2006 |
Nabha SM, Bonfil RD, Yamamoto HA, Belizi A, Wiesner C, Dong Z, Cher ML. Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis. Clinical & Experimental Metastasis. 23: 335-44. PMID 17136575 DOI: 10.1007/S10585-006-9042-X |
0.569 |
|
| 2006 |
Deng X, Bhagat S, Dong Z, Mullins C, Chinni SR, Cher M. Tissue inhibitor of metalloproteinase-3 induces apoptosis in prostate cancer cells and confers increased sensitivity to paclitaxel. European Journal of Cancer (Oxford, England : 1990). 42: 3267-73. PMID 16950615 DOI: 10.1016/J.Ejca.2006.07.003 |
0.442 |
|
| 2006 |
Bonfil RD, Sabbota A, Nabha S, Bernardo MM, Dong Z, Meng H, Yamamoto H, Chinni SR, Lim IT, Chang M, Filetti LC, Mobashery S, Cher ML, Fridman R. Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor. International Journal of Cancer. Journal International Du Cancer. 118: 2721-6. PMID 16381009 DOI: 10.1002/Ijc.21645 |
0.651 |
|
| 2006 |
Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. The Prostate. 66: 32-48. PMID 16114056 DOI: 10.1002/Pros.20318 |
0.59 |
|
| 2006 |
Bonfil RD, Dong Z, Trindade Filho JC, Zhao H, Ossenkowski P, Nabha S, Yamamoto H, Sabbota A, Chinni S, Vessella RL, Fridman R, Cher ML. 434: Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Promotes Tumor Growth and Bone Degradation in Prostate Cancer Bone Metastasis Journal of Urology. 175: 141-141. DOI: 10.1016/S0022-5347(18)32690-9 |
0.703 |
|
| 2005 |
Dong Z, Bonfil RD, Chinni S, Deng X, Trindade Filho JC, Bernardo M, Vaishampayan U, Che M, Sloane BF, Sheng S, Fridman R, Cher ML. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. The American Journal of Pathology. 166: 1173-86. PMID 15793297 DOI: 10.1016/S0002-9440(10)62337-1 |
0.707 |
|
| 2005 |
Liu XW, Taube ME, Jung KK, Dong Z, Lee YJ, Roshy S, Sloane BF, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Cancer Research. 65: 898-906. PMID 15705888 |
0.551 |
|
| 2005 |
Chinni SR, Sivalogan S, Dong Z, Filho JCT, Bonfil RD, Cher ML. 573: CXCL12 Chemokine-CXCR4 Receptor Interaction in Prostate Cancer Induces Akt Signaling, MMP-9 Expression, Motility and Invasion The Journal of Urology. 173: 156-157. DOI: 10.1016/S0022-5347(18)34813-4 |
0.494 |
|
| 2001 |
Dong Z, Nemeth JA, Cher ML, Palmer KC, Bright RC, Fridman R. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells. International Journal of Cancer. 93: 507-15. PMID 11477554 DOI: 10.1002/Ijc.1358 |
0.695 |
|
| 2000 |
Dong Z, Ghabrial M, Katar M, Fridman R, Berk RS. Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa. Investigative Ophthalmology & Visual Science. 41: 4189-94. PMID 11095614 |
0.58 |
|
| 1999 |
Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 5: 4105-10. PMID 10632347 |
0.671 |
|
| Show low-probability matches. |